Skip to main content

Dr. Quincy Chu, MD, FRCP(C)

Dr. Quincy Chu –past CCTG Investigational New Drug Committee Chair and new Thoracic Oncology chair
CCTG Investigational New Drug Committee Chair

Dr. Quincy Chu, Throacic Oncology Committee Chair

Dr. Quincy Chu is a medical oncologist who specializes in thoracic malignancies as well as early phase clinical trials. He received his BSc in biochemistry at McMaster University and M.D degree from University of Toronto in Ontario, Canada. Then completed a fellowship training in advanced novel anti-cancer therapeutics at the Institute for Drug Development, San Antonio Texas. He is an investigator with the Cross Cancer Institute’s New Drug Development Program, and the past chair of the CCTG Investigational New Drug program.

“Canadian researchers working together on CCTG collaborative clinical trials get novel and effective,
therapy to the patient faster, learn from each other and then achieve even more.”

Research Interests:

  • Thoracic malignancies and sarcomas
  • Phase I/II clinical trials of innovative anti-cancer agents
  • Molecular determinants of response and toxicities of innovative anti-cancer agents;

Publications

  • Not all publications available on PubMed